Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity

Dysregulation of miRNAs is a hallmark of cancer, modulating oncogenes, tumor suppressors, and drug responsiveness. The multi-kinase inhibitor sorafenib is one of the first-line drugs for advanced hepatocellular carcinoma (HCC), although the outcome for treated patients is heterogeneous. The identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Tussy, Pablo, Rodríguez-Agudo, Rubén, Fernández-Ramos, David, Barbier-Torres, Lucía, Zubiete-Franco, Imanol, Davalillo, Sergio López de, Herraez, Elisa, Goikoetxea-Usandizaga, Naroa, Lachiondo-Ortega, Sofia, Simón, Jorge, Lopitz-Otsoa, Fernando, Juan, Virginia Gutiérrez-de, McCain, Misti V., Perugorria, Maria J., Mabe, Jon, Navasa, Nicolás, Rodrigues, Cecilia M. P., Fabregat, Isabel, Boix, Loreto, Sapena, Victor, Anguita, Juan, Lu, Shelly C., Mato, José M., Banales, Jesus M., Villa, Erica, Reeves, Helen L., Bruix, Jordi, Reig, Maria, Marin, Jose J. G., Delgado, Teresa C., Martínez-Chantar, María L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163806/
https://www.ncbi.nlm.nih.gov/pubmed/34050139
http://dx.doi.org/10.1038/s41419-021-03827-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163806/
https://www.ncbi.nlm.nih.gov/pubmed/34050139
http://dx.doi.org/10.1038/s41419-021-03827-0

Ejemplares similares